journal article
LitStream Collection
Private vs public genomics?
2000 Nature
doi: 10.1038/35003001pmid: 10646564
Commercial sequencing of genomes has stimulated scientific progress. But the increasing value of such companies risks exacerbating the conflict between the interests of investors and of the public. Both need to worry.